Literature DB >> 1143362

Influence of isoprenaline and salbutamol on the threshold of electrically induced ventricular fibrillation in anaesthetized guinea pigs.

D Hellenbrecht, L Gortner.   

Abstract

Fibrillation threshold and heart rate were measured after increasing doses of (-)-isoprenaline and (plus or minus)-salbutamol. The initial values of 212 plus or minus 10 muA (x plus or minus SEM) and 211 plus or minus 10muA were decreased to 74 plus or minus 10 muA by low doses of (-)-isoprenaline (10-11- to 10-10 moles/kg i.v.), and to 89 plus or minus 11 muA by (plus or minus)-salbutamol (10-9- to 10-8- moles/kg i.v.). Higher doses, paradoxically, increased fibrillation threshold to initial values, (-)-isoprenaline: 2x10-9- moles/kg; (plus or minus)-salbutamol: 2x10-6- moles/kg. A linear increase in heart rate per 10-fold increase of either drug was observed, (-)-isoprenaline: 25 beats - min-1-; (plus or minus)-salbutamol: 14 beats - min-1-. The apparent beta2-selective property of salbutamol is documented by its low potency in changing fibrillation threshold and heart rate.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1143362     DOI: 10.1007/bf00510454

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  11 in total

1.  EFFECTS OF ALPHA AND BETA ADRENERGIC BLOCKING AGENTS ON CYCLOPROPANE-CATECHOLAMINE CARDIAC ARRHYTHMIAS.

Authors:  R L KATZ
Journal:  Anesthesiology       Date:  1965 May-Jun       Impact factor: 7.892

2.  A comparison of the cardiovascular actions of AQ 110 with those of isoprenaline and salbutamol.

Authors:  F Fogelman; H F Grundy
Journal:  Br J Pharmacol       Date:  1970-02       Impact factor: 8.739

3.  Dissociation of tracheobronchial and cardiac effects of some beta-adrenergic stimulants.

Authors:  L Hinds; R L Katz
Journal:  Anesthesiology       Date:  1971-05       Impact factor: 7.892

4.  A comparison of the beta-adrenoceptor stimulant properties of salbutamol, orciprenaline and soterenol with those of isoprenaline.

Authors:  J B Farmer; G P Levy; R J Marshall
Journal:  J Pharm Pharmacol       Date:  1970-12       Impact factor: 3.765

5.  Studies on carbuterol (SK & F 40383-A), a new selective bronchodilator agent.

Authors:  J R Wardell; D F Colella; A Shetzline; P J Fowler
Journal:  J Pharmacol Exp Ther       Date:  1974-04       Impact factor: 4.030

6.  Salbutamol and orciprenaline-induced changes in myocardial function.

Authors:  W G Nayler; I McInnes
Journal:  Cardiovasc Res       Date:  1972-11       Impact factor: 10.787

7.  [Determination of fibrillation threshold of guinea pig heart in spontaneous respiration by means of an intracardiac electrode].

Authors:  U Kirsch
Journal:  Arzneimittelforschung       Date:  1969-02

8.  The bronchodilator and cardiac stimulant effects of Thll65a, salbutamol and isoproterenol.

Authors:  R E Giles; J C Williams; M P Finkel
Journal:  J Pharmacol Exp Ther       Date:  1973-09       Impact factor: 4.030

9.  Measurement of hydrophobicity, surface activity, local anaesthesia, and myocardial conduction velocity as quantitative parameters of the non-specific membrane affinity of nine -adrenergic blocking agents.

Authors:  D Hellenbrecht; B Lemmer; G Wiethold; H Grobecker
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1973       Impact factor: 3.000

10.  Some observations on the -adrenoceptor agonist properties of the isomers of salbutamol.

Authors:  R T Brittain; J B Farmer; R J Marshall
Journal:  Br J Pharmacol       Date:  1973-05       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.